RegulyzeAshar-bala
Medicago sativa · Extract
Ashar-bala (Medicago sativa) is a nutraceutical permitted for use in nutraceuticals and health supplements under India's FSSAI framework. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | As specified / GMP | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About Ashar-bala
Ashar-bala is tracked in the Regulyze Ingredient Intelligence database as a nutraceutical (Medicago sativa). The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is Ashar-bala permitted in nutraceuticals under FSSAI (India)?
Ashar-bala (Medicago sativa) (listed in the regulation as “Medicago sativa extract”) is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of Ashar-bala?
No single numeric limit is listed in the source for Ashar-bala; permitted use is at GMP or as specified. Confirm against the current regulation.
What product category does Ashar-bala belong to?
Ashar-bala is classified under: Nutraceuticals, Botanicals.
What is the botanical (scientific) name of Ashar-bala?
Ashar-bala corresponds to Medicago sativa, with the extract used in nutraceutical preparations.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.